期刊文献+

左乙拉西坦联合奥卡西平治疗小儿癫痫的疗效及安全性 被引量:12

Efficacy and Safety of Levetiracetam Combined with Oxcarbazepine in Treatment of Children with Epilepsy
下载PDF
导出
摘要 目的:探讨左乙拉西坦联合奥卡西平治疗小儿癫痫的疗效及安全性。方法:选取2015年6月—2016年8月南昌大学第一附属医院收治的癫痫患儿88例作为研究对象,以随机数字表法分为观察组和对照组,每组44例。对照组患儿给予奥卡西平治疗,观察组患儿在对照组的基础上加用左乙拉西坦治疗。观察两组患儿的癫痫发作、脑电图改善及不良反应发生情况。结果:观察组患儿的癫痫发作总有效率为97.73%(43/44),明显高于对照组的86.36%(38/44);观察组患儿的脑电图改善总有效率为95.45%(42/44),明显高于对照组的77.27%(34/44);观察组患儿不良反应发生率明显低于对照组,差异均有统计学意义(P<0.05)。结论:左乙拉西坦联合奥卡西平治疗小儿癫痫的疗效显著,明显改善了患儿灰质痫样放电,且安全性较高。 OBJECTIVE: To probe into the efficacy and safety of levetiracetam combined with oxcarbazepine in treatment of children with epilepsy. METHODS: 88 children with epilepsy admitted into the First Affiliated Hospital of Nanchang University from Jun. 2015 to Aug. 2016 were selected to be divided into observation group and control group via the random number table,with 44 cases in each. The control group was given oxcarbazepine,while the observation group additionally received levetiracetam based on the control group. The epilepsy,improvement of electroencephalogram( EEG) and incidence of adverse drug reactions in two groups were observed. RESULTS: The total effective rate of epilepsy in observation group was 97. 73%( 43/44),significantly higher than that in control group [86. 36%( 38/44) ];the total effective rate of improvement of EEG in observation group was 95. 45%( 42/44),significantly higher than that in control group [77. 27%( 34/44) ]; the incidence of adverse drug reactions of observation group was significantly lower than that of control group,with statistically significant difference( P〈0. 05). CONCLUSIONS: The efficacy of levetiracetam combined with oxcarbazepine in treatment of children with epilepsy is remarkable,which can effectively improve the gray epileptiform discharge with high safety.
作者 章素芳 程鹏
出处 《中国医院用药评价与分析》 2017年第8期1068-1069,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 奥卡西平 左乙拉西坦 小儿癫痫 Oxcarbazepine Levetiracetam Children with epilepsy
  • 相关文献

参考文献11

二级参考文献107

  • 1Luoni C,Bisulli F,Canevini MP,et al.Determinants of healthrelated quality of life in pharmacoresistant epilepsy:results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments[J].Epilepsia,2011,52(12):2181-2191.
  • 2Taylor RS,Sander JW,Taylor RJ,et al.Predictors of health-related quality of life and costs in adults with epilepsy:a systematic review[J].Epilepsia,2011,52(12):2168-2180.
  • 3Lyseng-Williamson KA.Levetiracetam:a review of its use in epilepsy[J].Drugs.2011;71(4):489-514.
  • 4Lee YJ,Kang HC,Kim HD,et al.Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy[J].Pediatr Neurol,2010,42(2):86-92.
  • 5Incecik F,Hergüner MO,Altunbasak S.The efficacy and side effects of levetiracetam on refractory epilepsy in children[J].J Pediatr Neurosci,2012,7(1):19-22.
  • 6Ozkale Y,Ozkale M,Saygi S,et al.Long-Term Accidental Overdose of Levetiracetam in an Infant[J].J Child Neurol,2013,20(20):1-3.
  • 7Bodmer M,Monte AA,Kokko J,et al.Safety of non-therapeu-tic levetiracetam ingestions-a poison center based study[J].Pharmacoepidemiol Drug Saf,2011,20(4):366-369.
  • 8Cho JR,Koo DL,Joo EY,et al.Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naive epilepsy patients[J].Clin Neurophysiol,2012,123(5):883-891.
  • 9Khurana DS, Kothare SV, Valcncia I, et al. Levetiracetarn monotherapy in children with epilepsy [ J ]. Pediatr Neurol, 2007, 36 (4): 227-230.
  • 10Franzoni E, Gentile V, Pellicciari A, et al. Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy [J]. Neurol, 2009, 256 (9): 1527-1532.

共引文献186

同被引文献98

引证文献12

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部